The frontal/subcortical dementias: Common dementing illnesses associated with prominent and disturbing behavioral changes

Geriatrics

Volumn 61, Issue 8, 2006, Pages 23-27

  Stewart, Jonathan T ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Bay Pines VA Medical Center   (United States)

Author keywords

Alcoholic dementia; Basal ganglia; Dementia; Frontal lobe; Frontotemporal dementia; Vascular dementia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEUPRORELIN; LORAZEPAM; MEDROXYPROGESTERONE ACETATE; OLANZAPINE; PAROXETINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; ZIPRASIDONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOLIC DEMENTIA; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COGNITION; DECISION MAKING; DEEP VEIN THROMBOSIS; DEMENTIA; DISEASE ASSOCIATION; FRONTAL CORTEX; FRONTAL DEMENTIA; HUMAN; HYPERGLYCEMIA; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; PLANNING; SUBCORTICAL DEMENTIA;

ALZHEIMER DISEASE; ATROPHY; BRAIN; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FRONTAL LOBE; HUMANS; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747614590     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Darvesh S, Freedman M. Subcortical dementia: A neurobehavioral approach. Brain Cogn 1996; 31(2):230-49.
2. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37(2):121-30.
3. Cummings JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 1995; 769:1-13.
4. Duke LM, Kaszniak AW. Executive control functions in degenerative dementias: A comparative review. Neuropsychol Rev 2000; 10(2):75-99.
5. Levin H, Kraus MF. The frontal lobes and traumatic brain injury. J Neuropsychiatry Clin Neurosci 1994; 6(4):443-54.
6. Archibald SJ, Mateer CA, Kerns KA. Utilization behavior: Clinical manifestations and neurological mechanisms. Neuropsychol Rev 2001; 11(3):117-30.
7. stewart JT, Gonzalez-Perez E, Zhu Y, Robinson BE. Cognitive predictors of resistiveness in dementia patients. Am J Geriatr Psychiatry 1999; 7(3):259-63.
8. Stewart JT. Behavioral and emotional complications of neurological disorders. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice. London: Martin Dunitz; 2003:2855-2870.
9. Kahokehr A, Siegert RJ, Weatherall M. The frequency of executive cognitive impairment in elderly rehabilitation inpatients. J Geriatr Psychiatry Neurol 2004; 17(2):68-72.
10. Luria AR. Higher Cortical Functions in Man. New York: Basic Books; 1966.
11. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology 2000; 55(11):1621-6.
12. Royall DR, Mahurin RK, Gray K. Bedside assessment of executive cognitive impairment: The Executive Interview. J Am Geriatr Soc 1992; 40(12):1221-6.
13. Roman GC. Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003; 51(5 Suppl Dementia):S296-304.
14. Hanon O, Forette F. Prevention of dementia: Lessons from SYST-EUR and PROGRESS. J Neurol Sci 2004; 226(1-2):71-4.
15. Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 1989; 37(6):549-55.
16. Black S, Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34(10):2323-30.
17. Kertesz A, Munoz DG. Frontotemporal dementia. Med Clin N Am 2002; 86(3):501-18.
18. Victor M. Persistent altered mentation due to ethanol. Neurol Clin 1993; 11(3):639-61.
19. Clifford DB. AIDS dementia. Med Clin North Am 2002; 86(3):537-50.
20. Nadeau SE, Malloy PF, Andrew ME. A crossover trial of bromocriptine in the treatment of vascular dementia. Ann Neurol 1988; 24(2):270-2.
21. Shankle WR, Nielson KA, Cotman CW. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. Alzheimer Dis Assoc Disord 1995; 9(4):233-7.